Form 4 for TXG 10x Genomics, Inc.
Accepted 2023-08-03 00:00:00 ET · period of report 2023-08-01 · accession 0001610717-23-000222 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2023-08-03 | 2023-08-01 | TXG | Hindson Benjamin J. | See Remarks, Dir | M - OptEx | $11.48 | +6,970 | 291.2K | +2% | +$80.0K |
| DMT | 2023-08-03 | 2023-08-01 | TXG | Hindson Benjamin J. | See Remarks, Dir | S - Sale+OE | $62.21 | -6,970 | 289.5K | -2% | -$433.6K |
| DT | 2023-08-03 | 2023-08-01 | TXG | Hindson Benjamin J. | See Remarks, Dir | M - OptEx | $0.00 | -6,970 | 23.3K | -23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-08-01 | M | A | 6,970 | $11.48 | 291,206 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-08-01 | S | D | 5,243 | $62.36 | 284,236 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $62.12 to $62.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2023-08-01 | S | D | 1,727 | $61.77 | 289,479 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $61.12 to $62.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Derivative | Stock Option (right to buy) | 2023-08-01 | M | D | 6,970 | $0.00 | 23,312 | D | $11.48 · — to 2029-05-10 | 6,970 Class A Common Stock | (F4) All of the shares subject to the option are fully vested and exercisable as of the date hereof. |